Akero Therapeutics Inc (AKRO)

11:18 AM

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $76.29 Consensus Target Price from Brokerages - MarketBeat

11:18 AM

09:51 AM

Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); ... - Bluefield Daily Telegraph

09:51 AM

09:51 AM

Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView

09:51 AM

07:53 AM

Alkeon Capital Management LLC Sells 1,563,736 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

07:53 AM

May 04, 2025

5AM Venture Management LLC Takes Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 04, 2025

May 04, 2025

Renaissance Technologies LLC Invests $579,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

May 04, 2025

May 04, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Schonfeld Strategic Advisors LLC - MarketBeat

May 04, 2025

May 04, 2025

Aquatic Capital Management LLC Buys 14,841 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 04, 2025

May 04, 2025

Invesco Ltd. Purchases 21,086 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 04, 2025

May 04, 2025

Akero Therapeutics (AKRO) Expected to Announce Quarterly Earnings on Friday - MarketBeat

May 04, 2025

May 04, 2025

T. Rowe Price Investment Management Inc. Decreases Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 04, 2025

May 03, 2025

Foresite Capital Management VI LLC Makes New $10.15 Million Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 03, 2025

May 03, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $256,437.50 in Stock - MarketBeat

May 03, 2025

May 03, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Price T Rowe Associates Inc. MD - MarketBeat

May 03, 2025

May 03, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stake Boosted by Tower Research Capital LLC TRC - MarketBeat

May 03, 2025

May 03, 2025

Brokerages Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $76.29 - Defense World

May 03, 2025

May 02, 2025

Akero Therapeutics (AKRO) Projected to Post Quarterly Earnings on Friday - Defense World

May 02, 2025

May 02, 2025

Dark Forest Capital Management LP Buys Shares of 16,893 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 02, 2025

May 01, 2025

Wells Fargo & Company MN Acquires 7,587 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 01, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

May 01, 2025

How does Akero Therapeutics Inc (AKRO) change from a tortoise to a hare? - Sete News

May 01, 2025

May 01, 2025

AKRO’s 2023 Market Dance: Up 63.95% – Time to Invest? - investchronicle.com

May 01, 2025

May 01, 2025

Emerald Mutual Fund Advisers Trust Lowers Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

May 01, 2025

May 01, 2025

Akero Therapeutics (AKRO) Receives Buy Rating with Promising Pot - GuruFocus

May 01, 2025

Apr 30, 2025

Akero Therapeutics Inc (AKRO) receives a Buy rating from BofA Securities - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Jump Financial LLC Decreases Stake in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Apr 30, 2025

Apr 30, 2025

Akero (AKRO) Among Leading FGF21 Developers, Says Cantor Fitzgerald | AKRO Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

Do investors need to be concerned about Akero Therapeutics Inc (AKRO)? - uspostnews.com

Apr 30, 2025

Apr 30, 2025

Akero Therapeutics Announces Upcoming Poster And Oral Presentations At The Easl Congress 2025 - marketscreener.com

Apr 30, 2025

Apr 30, 2025

Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025 - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

Breakthrough: Akero's Efruxifermin Demonstrates Fibrosis Improvement in 96-Week MASH Trial - Stock Titan

Apr 30, 2025

Apr 29, 2025

(AKRO) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Apr 29, 2025

Apr 29, 2025

Quarterly Metrics: Quick and Current Ratios for Akero Therapeutics Inc (AKRO) - DWinneX

Apr 29, 2025

Apr 29, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by Barclays PLC - American Banking and Market News

Apr 29, 2025

Apr 29, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Increased by Invesco Ltd. - Defense World

Apr 29, 2025

Apr 28, 2025

Marshall Wace LLP Invests $7.65 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Apr 28, 2025

Apr 28, 2025

Investor’s Delight: Akero Therapeutics Inc (AKRO) Closes Weak at 38.64, Down -4.55 - DWinneX

Apr 28, 2025

Apr 27, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Position Boosted by Wells Fargo & Company MN - Defense World

Apr 27, 2025

Apr 26, 2025

260,000 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by B Group Inc. - MarketBeat

Apr 26, 2025

Apr 26, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lifted by Rock Springs Capital Management LP - MarketBeat

Apr 26, 2025

Apr 25, 2025

Akero Therapeutics Inc [AKRO] stock for 343,962 USD was sold by Yale Catriona - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

AMRX Stock Sees Surge of Approximately 3.34% in Last Five Days - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Insider’s View: Deciphering Akero Therapeutics Inc (AKRO)’s Financial Health Through Ratios - DWinneX

Apr 25, 2025

Apr 25, 2025

Akero Therapeutics Inc (AKRO) looking to reclaim success with recent performance - Sete News

Apr 25, 2025

Apr 24, 2025

Akero Therapeutics Inc (AKRO) shows promising results - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Walleye Capital LLC Takes $3.75 Million Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Apr 24, 2025

Apr 23, 2025

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to - Bluefield Daily Telegraph

Apr 23, 2025